US Food and Drug Administration (USFDA) has completed inspection at JB Chemicals & Pharmaceuticals’ solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat with one minor procedural observation.
This observation does not impact continuity of the business and the company would continue its manufacturing activities in current good manufacturing practice (cGMP) compliant manner. The Company proposes to address this observation in the next 15 days. The said inspection was carried-out from February 03, 2020 to February 07, 2020. This is the 10th consecutive successful inspection for this facility.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
